发明名称 TABLET FORMULATION
摘要 <p><P>PROBLEM TO BE SOLVED: To provide a cough/cold tablet formulation with controlled release and absorption assuring a predetermined release rate and effective tablet formulation by accurately controlling release of a plurality of active ingredients. <P>SOLUTION: The cough/cold tablet formulation with the controlled release and absorption comprises a tablet core containing the plurality of active ingredients, in particular an antihistamine, a decongestant and a cough suppresant, together with a pharmaceutically acceptable excipient. A specific permeable membrane surrounds the core and contains at least one of the active ingredients present in the core, wherein the membrane contains a major amount of a component which is impermeable to each of the active ingredients and a minor amount of a component which, when the tablet is placed in an aqueous environment, permits the release of each of the active ingredients and the pharmaceutically acceptable excipient present in the core, at a rate allowing controlled release and absorption thereof. <P>COPYRIGHT: (C)2006,JPO&NCIPI</p>
申请公布号 JP2006001941(A) 申请公布日期 2006.01.05
申请号 JP20050225315 申请日期 2005.08.03
申请人 ELAN CORP PLC 发明人 MYERS MICHAEL;MULLIGAN SEAMUS
分类号 A61K9/22;A61K9/24;A61K9/28;A61K31/4402;A61K31/4741;A61K31/485;A61K47/02;A61K47/04;A61K47/10;A61K47/12;A61K47/26;A61K47/30;A61K47/32;A61P11/14;A61P29/00;A61P43/00 主分类号 A61K9/22
代理机构 代理人
主权项
地址